ORAI1 and neoplasm: Ohmline, a lipid inhibitor of SK3 channels [71], moved the SK3-Orai1 complex outside of lipid rafts and impaired the subsequent SK3-dependent Ca2+ entry, tumor cell migration, and bone metastases [70].